CD4 and cancer: The restimulated CD4+ T cells growing with cancer from day 12 up to day 15 (T15M) exhibited PD-L1 overexpression at both the protein and transcript levels, although when these cells were separated from cancer cells on day 15 and further cultured without cancer cells (T18-M) the PD-L1 expression was inhibited.